GD2-CAR T Cells for Pediatric Brain Tumours — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

GD2-CAR T Cells for Pediatric Brain Tumours — Stella

Home/Brain Tumor, Pediatric/

View on ClinicalTrials.gov

Recruiting

Back to Brain Tumor, Pediatric trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Italy

Ospedale Pediatrico Bambino Gesù, Roma, Italy

Key details

Phase

Early testing

Sponsor

Bambino Gesù Hospital and Research Institute

Enrollment target

~54 participants

Started

November 2023

Primary completion

November 2027

Age range

6 Months – 30 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.